Cost-effectiveness analysis of health technologies when evidence is scarce
نویسنده
چکیده
.................................................................................................................. I SAMMANFATTNING ............................................................................................. II LIST OF PAPERS ...................................................................................................... III ABBREVIATIONS .................................................................................................... IV INTRODUCTION ....................................................................................................... 1 Aims ........................................................................................................................ 3 Overview of the thesis ........................................................................................ 4 METHODOLOGICAL FRAMEWORK .................................................................. 5 Cost-effectiveness analysis ................................................................................ 5 Choice of effect measure in economic evaluations .................................... 6 Methods to estimate cost-effectiveness ........................................................... 7 Decision modelling ......................................................................................... 7 Handling uncertainty ..................................................................................... 8 Estimating the value of further research ..................................................... 9 Capturing experts beliefs ................................................................................. 11 THE CASE STUDIES ............................................................................................... 14 Cost-effectiveness of Airsonett Airshower (Paper I) .................................. 14 Results (Paper I) ............................................................................................ 15 Implications for policy (Paper I) ................................................................. 18 Cost-effectiveness of C-Leg (Paper II & III) ................................................. 19 Results (Paper II & III) .................................................................................. 20 Implications for policy (Paper II & III) ...................................................... 23 Cost-effectiveness of screening for hypertrophic cardiomyopathy (Paper IV) .......................................................................................................................... 25 Results (Paper IV) ......................................................................................... 26 Implications for policy (Paper IV) .............................................................. 27
منابع مشابه
Use of Cost-Effectiveness Data in Priority Setting Decisions: Experiences from the National Guidelines for Heart Diseases in Sweden
Background The inclusion of cost-effectiveness data, as a basis for priority setting rankings, is a distinguishing feature in the formulation of the Swedish national guidelines. Guidelines are generated with the direct intent to influence health policy and support decisions about the efficient allocation of scarce healthcare resources. Certain medical conditions may be given higher priority ran...
متن کاملDon’t Discount Societal Value in Cost-Effectiveness; Comment on “Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness”
As healthcare resources become increasingly scarce due to growing demand and stagnating budgets, the need for effective priority setting and resource allocation will become ever more critical to providing sustainable care to patients. While societal values should certainly play a part in guiding these processes, the methodology used to capture these values need not necessarily be limited to mul...
متن کاملProblems and Promises of Health Technologies: The Role of Early Health Economic Modeling
Background To assess whether early health economic modeling helps to distinguish those healthcare innovations that are potentially cost-effective from those that are not potentially cost-effective. We will also study what information is retrieved from the health economic models to inform further development, research and implementation decisions. Methods We performed s...
متن کاملHow Useful Are Early Economic Models?; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling”
Early economic modelling has long been recommended to aid research and development (R&D;) decisions in medical innovation, although they are less frequently published and critically appraised. A review of 30 innovations by Grutters et al provides an opportunity to evaluate how early models are used in practice. The evidence of early models can be used to inform two types...
متن کاملEvidence-Informed Deliberative Processes for Universal Health Coverage: Broadening the Scope; Comment on “Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness”
Universal health coverage (UHC) is high on the global health agenda, and priority setting is fundamental to the fair and efficient pursuit of this goal. In a recent editorial, Rob Baltussen and colleagues point to the need to go beyond evidence on cost-effectiveness and call for evidence-informed deliberative processes when setting priorities for UHC. Such processes are crucial at every step on...
متن کامل